Pemmaraju, N. and Lane, A. A. (2020) “Response to Comment on: ‘First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level’”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.302103.